Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OligoProgressive Metastatic Disease”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Large-scale testing (Phase 3)Looking for participantsNCT06686771
What this trial is testing

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Canadian Cancer Trials Group 320
Testing effectiveness (Phase 2)Looking for participantsNCT04974671
What this trial is testing

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressive+1 more
Yale University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05301881
What this trial is testing

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

Who this might be right for
Breast Cancer InvasiveMetastatic CancerOligoprogressive
The Netherlands Cancer Institute 56
Not applicableLooking for participantsNCT06918951
What this trial is testing

Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

Who this might be right for
OligoprogressionOligometastatic DiseaseOligoProgressive Metastatic Disease
British Columbia Cancer Agency 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Not applicableLooking for participantsNCT07112170
What this trial is testing

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaOligoProgressive Metastatic Disease
University Health Network, Toronto 52
Not applicableLooking for participantsNCT04838899
What this trial is testing

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Who this might be right for
OligoprogressiveCastration-Resistant Prostate Cancer
Sunnybrook Health Sciences Centre 30
Testing effectiveness (Phase 2)Looking for participantsNCT06676722
What this trial is testing

SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy

Who this might be right for
Nasopharyngeal Cancinoma (NPC)SBRTImmunotherapy
The First Affiliated Hospital of Xiamen University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07333651
What this trial is testing

125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer

Who this might be right for
Oligometastatic Disease
Li Min 90
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Testing effectiveness (Phase 2)Looking for participantsNCT04989725
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

Who this might be right for
Metastatic CancerOligoprogressive
Centre hospitalier de l'Université de Montréal (CHUM) 46
Not applicableActive Not RecruitingNCT04624828
What this trial is testing

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Who this might be right for
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas 40
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Not applicableNot Yet RecruitingNCT06489821
What this trial is testing

STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer

Who this might be right for
Metastatic Breast CancerOligoprogression
Juravinski Cancer Center 36
Large-scale testing (Phase 3)Looking for participantsNCT06841172
What this trial is testing

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Who this might be right for
OligoProgressive Metastatic DiseaseHepatocellular Carcinoma (HCC)Radiotherapy+1 more
Shandong Cancer Hospital and Institute 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT04405401
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM) 68
Next Page